Theravance Biopharma, Inc. Ordinary Shares Share Price
NASDAQ: TBPH | Small CapTheravance Biopharma, Inc. Ordinary Shares Stock Performance
Open $16.91 | Prev. Close $16.92 | Circuit Range N/A |
Day Range $16.91 - $16.95 | Year Range $11.09 - $21.01 | Volume 20,007 |
Average Traded $16.93 |
Theravance Biopharma, Inc. Ordinary Shares Share Price Today
As of 10 August 2026, Theravance Biopharma, Inc. Ordinary Shares's share price is $16.93. The stock opened at $16.91, compared to its previous close of $16.92. During today's trading session, Theravance Biopharma, Inc. Ordinary Shares's share price traded between $16.91 and $16.95, with an average price of $16.93. Over the past 52 weeks, the stock has recorded a high of $21.01 and a low of $11.09. In terms of performance, Theravance Biopharma, Inc. Ordinary Shares's share price has declined by 7.39% over the last six months and is up 21.97% on a year-on-year basis.
Theravance Biopharma, Inc. Ordinary Shares Share Price Chart
Theravance Biopharma, Inc. Ordinary Shares Stock Fundamentals & Key Indicators
Market Cap $851.87M | PE Ratio (TTM) 8.06 | Dividend Yield N/A |
EPS (TTM) $2.10 | Revenue (TTM) $107.46M | Return On Equity (TTM) 35.69% |
Profit Margin 98.54% | Debt to Equity 0.13 | Quarterly Earnings Growth YoY 128.47% |
Theravance Biopharma, Inc. Ordinary Shares Quarterly Profit & Loss
All figures in USD
Theravance Biopharma, Inc. Ordinary Shares Annual Profit & Loss
All figures in USD
About Theravance Biopharma, Inc. Ordinary Shares
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes of medicines in the United States. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). The company's product includes Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; and TRELEGY for the treatment of COPD and asthma. It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
Theravance Biopharma, Inc. Ordinary Shares Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $16.87 | $16.94 | +0.47% |
Jul 2026 | $17.00 | $16.86 | -0.88% |
Jun 2026 | $15.98 | $17.01 | +6.01% |
May 2026 | $16.59 | $16.05 | -4.15% |
Apr 2026 | $16.40 | $16.74 | +3.09% |
Mar 2026 | $18.56 | $16.24 | -11.17% |
Feb 2026 | $19.52 | $18.28 | -3.54% |
Jan 2026 | $18.55 | $18.95 | +1.39% |
Dec 2025 | $20.07 | $18.69 | -8.02% |
Nov 2025 | $14.80 | $20.32 | +38.51% |
Oct 2025 | $14.66 | $14.67 | +0.48% |
Sep 2025 | $14.10 | $14.60 | +5.19% |
TBPH Share Price FAQs
What is Theravance Biopharma, Inc. Ordinary Shares share price today?
What is the 52 week high and 52 week low of Theravance Biopharma, Inc. Ordinary Shares stock?
What is TBPH's market capitalisation today?
What is TBPH's net income for the last quarter?
What is the 5 year returns of TBPH?
What is the high & low stock price of TBPH today?
Can I buy TBPH shares in India?